| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/01/2001 | EP1119627A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 08/01/2001 | EP1119625A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119622A2 Bax-mediated apoptosis modulating reagents and methods |
| 08/01/2001 | EP1119621A2 G-protein coupled receptor proteins |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119618A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods |
| 08/01/2001 | EP1119617A2 Fusions of scaffold proteins with random peptide libraries |
| 08/01/2001 | EP1119616A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 08/01/2001 | EP1119615A1 PRODUCTION OF ssDNA IN VIVO |
| 08/01/2001 | EP1119614A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119583A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use |
| 08/01/2001 | EP1119582A2 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 08/01/2001 | EP1119581A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
| 08/01/2001 | EP1119580A1 ANTISENSE MODULATION OF EXPRESSION OF TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS (TRAFs) |
| 08/01/2001 | EP1119579A1 Antisense modulation of bcl-x expression |
| 08/01/2001 | EP1119576A1 Isolation method for nucleic acid and apparatus |
| 08/01/2001 | EP1119375A1 Methods and adjuvants for stimulating mucosal immunity |
| 08/01/2001 | EP1119369A1 Vascular endothelial growth factor 3 |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 08/01/2001 | EP1017843B1 Method for determining active agents |
| 08/01/2001 | EP0889959B1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 08/01/2001 | EP0862629B1 Epithelial membrane protein-1 |
| 08/01/2001 | EP0763133B1 Method for detecting a target nucleic acid |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |
| 08/01/2001 | EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci |
| 08/01/2001 | EP0698106B1 Marker gene |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 08/01/2001 | EP0654532B1 Antimucoglycoprotein monoclonal antibody |
| 08/01/2001 | EP0643135B1 Dna encoding aspartokinase iii mutants and their use for the production of l-threonine by fermentation |
| 08/01/2001 | EP0590012B1 Mutant proteolytic enzymes from bacillus |
| 08/01/2001 | EP0498827B1 Improved plasmid vectors for cellular slime moulds of the genus dictyostelium |
| 08/01/2001 | EP0463024B1 Dna construct and modified yeast |
| 08/01/2001 | CN1306579A Plant selectable marker and plant transformation method |
| 08/01/2001 | CN1306578A Transgenic plants with modified activity of plastidial ADP/ATP translocator |
| 08/01/2001 | CN1306577A Multiply-substituted protease variants |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 08/01/2001 | CN1306574A Attenuated virus oka strain gene 62 and method for identifying virus strain for attenuated live vaccine by using same |
| 08/01/2001 | CN1306573A Novel human thrombopoietin mutein |
| 08/01/2001 | CN1306572A Soluble T cell receptor |
| 08/01/2001 | CN1306571A Methods for means for obtaining modified phenotypes |
| 08/01/2001 | CN1306569A Stabilized transient gene expression |
| 08/01/2001 | CN1306568A Human bile salt-stimulated lipase (BSSL) obtainable from transgenic sheep |
| 08/01/2001 | CN1306542A Moraxella catharralis proteins |
| 08/01/2001 | CN1306437A Vaccine |
| 08/01/2001 | CN1306436A Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/01/2001 | CN1306402A Method of preparing objects contg. DNA |
| 08/01/2001 | CN1306390A Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 08/01/2001 | CN1306090A Low-virulent vaccine K genom sequence of tomato mosaic |
| 08/01/2001 | CN1306087A Method for culturing antibody gene enzyme |
| 08/01/2001 | CN1306007A Dry cell factor |
| 08/01/2001 | CN1306006A BioHNTP13 molecular weight of 13 KDa and its coding sequence |
| 08/01/2001 | CN1069062C Use of follicle-stimulating hormone |
| 08/01/2001 | CA2330023A1 Levodione reductase gene and use thereof |
| 07/31/2001 | US6269312 Apparatus and method for automated protein design |
| 07/31/2001 | US6268552 Dna construct; for dicotyledonous plants |
| 07/31/2001 | US6268550 Introducing expression cassette including dna which codes for maize acetyl coenzyme a carboxylate including chloroplast transit peptide into cells, regenerating transformed plant cells to differentiated plant having altered oil content |
| 07/31/2001 | US6268549 DNA sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides |
| 07/31/2001 | US6268548 Isolation and characterization of gene encoding maize heat shock protein |
| 07/31/2001 | US6268547 Culturing immature plant embryos to form callus, transforming with dna coding for cyanamide hydratase, selecting for resistant cells by growing on media containing cyanamide, then regenerating transgenic plants |
| 07/31/2001 | US6268546 Ovary-tissue transcriptional factors |
| 07/31/2001 | US6268545 Transgenic non-human mammal comprising a rabbit WAP promoter, uses thereof, and a DNA construct comprising the rabbit WAP promoter |
| 07/31/2001 | US6268516 Cationic amphiphilic lipids for liposomal gene transfer |
| 07/31/2001 | US6268492 Lysing cells, precipitating chromosomal dna and cell wall components to form flocculent solution, applying to depth filter to capture precipitate and allow non-chromosomal dna to pass through filter; not centrifuged before filtration |
| 07/31/2001 | US6268491 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/31/2001 | US6268490 Bicyclonucleoside and oligonucleotide analogues |
| 07/31/2001 | US6268487 Purification of biologically active peptides from milk |
| 07/31/2001 | US6268486 Contacting mixture of polypeptide and impurities with specific monoclonal antibody so that binding occurs, desorbing polypeptide from antibody, and collecting polypeptide; immunoaffinity chromatography |
| 07/31/2001 | US6268485 Down-regulation resistant C3 convertase |
| 07/31/2001 | US6268482 Recombinant cytokine designated LERK-6 |
| 07/31/2001 | US6268480 Amino acid sequence of interleukin-13bc protein; recombinant production; drug screening of binding inhibitors |
| 07/31/2001 | US6268479 Intracellular amyloid-beta peptide binding (ERAB) polypeptide |
| 07/31/2001 | US6268478 From new world primate and having specific vitamin d binding activity of at least 17,588-fold greater than endogenous protein; therapy and diagnosis of osteoporosis and hypercalcemia; drug screening |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268476 EPH receptor ligands, and uses related thereto |
| 07/31/2001 | US6268475 Hexapeptides containing cysteinsulfinic and cysteinesulfenic acid |
| 07/31/2001 | US6268473 Amino acid sequences; muscle relaxants; treating benign essential blepharospasm and other forms of focal dystonia; antiwrinkle agents |
| 07/31/2001 | US6268471 Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268350 Polynucleotides for inhibiting metastasis and tumor cell growth |
| 07/31/2001 | US6268347 Alleviating neuropathic pain |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268341 These polypeptides are useful for treating diseases wherein antagonism of hupar is therapeutically beneficial. |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/31/2001 | US6268334 Cells include cardiovascular cells, and the peptide may be delivered in a stent to treat or prevent restinosis. |
| 07/31/2001 | US6268328 Variant EGIII-like cellulase compositions |
| 07/31/2001 | US6268221 Drug screening for compound which binds to receptor by transforming host cell with recombinant expression contruct encoding the receptor, expressing in culture, and analyzing cells to determine binding |
| 07/31/2001 | US6268218 Method for sensing and processing fluorescence data from multiple samples |
| 07/31/2001 | US6268216 Reagents and methods for the screening of compounds useful in the treatment of neurological diseases |
| 07/31/2001 | US6268213 Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
| 07/31/2001 | US6268212 Tissue specific transgene expression |
| 07/31/2001 | US6268211 Transgene of complete human immunodeficiency virus genome except having 5'long terminal repeat, portion of 5'leader, and portion of 3' long terminal repeat deleted; also includes regulatory sequences for gene expression; animal models |
| 07/31/2001 | US6268207 Resolution of enantiomers from a mixture of (1r,2s)/(1s,2s)-1-amino-2-vinylcyclopropyl carboxylic acid methyl ester comprising the step of treating said mixture with an esterase to obtain the corresponding (1r,2s) enantiomer |
| 07/31/2001 | US6268201 IniB, iniA and iniC genes of mycobacteria and methods of use |
| 07/31/2001 | US6268199 An infectious clone transfected with a recombinant nucleic acid of the porcine reproductive respiratory syndrome virus; vaccines |
| 07/31/2001 | US6268198 A recombinant dna molecule encoding an orpinomyces cellulase protein; for the conversion of cellulose to glucose for carbon sources for fuel and chemical production |